Letter to the Editor: Exposure–response or clearance–response relationship in immune checkpoint therapy?—A comment on ‘correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer’ by Basak et al

Letter to the Editor: Exposure–response or clearance–response relationship in immune checkpoint therapy?—A comment on ‘correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer’ by Basak et al

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2019-06, Vol.114, p.25-26
Hauptverfasser: Badawi, Mohamed, Coss, Christopher C., Phelps, Mitch A.
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents, Immunological
Carcinoma, Non-Small-Cell Lung
Exposure
Humans
Immune checkpoint
Immune clearance
Immunotherapy
Lung cancer
Lung Neoplasms
Monoclonal antibodies
Nivolumab
Targeted cancer therapy
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2019.02.017